Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Brenner

Showing results (121-130 of 147) with videos related to

Pageof 15
Sort By:
Brain, Behavior, and Immunity|November 5, 2024
Acute exercise boosts NAD<sup>+</sup> metabolism of human peripheral blood mononuclear cellsDavid Walzik, Niklas Joisten, Alexander Schenk, et al.
Eclinicalmedicine|December 8, 2025
Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trialChao-Yi Wu, William Cody Reynolds, Isabel Abril, et al.
Molecular Cell|May 6, 2020
NAD<sup>+</sup> Controls Circadian Reprogramming through PER2 Nuclear Translocation to Counter AgingDaniel C Levine, Heekyung Hong, Benjamin J Weidemann, et al.
Pediatric Blood & Cancer|October 10, 2024
Feasibility of telehealth exercise and nicotinamide riboside supplementation in survivors of childhood cancer at risk for diabetes: A pilot randomized controlled trialRusha Bhandari, Kara Lukas, Kyuwan Lee, et al.
Molecular Metabolism|July 29, 2017
Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cellsRachel S Fletcher, Joanna Ratajczak, Craig L Doig, et al.
Geroscience|November 23, 2023
A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairmentMiranda E Orr, Eithan Kotkowski, Paulino Ramirez, et al.
The Journal of Clinical Investigation|January 13, 2022
Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytesJing Wu, Komudi Singh, Amy Lin, et al.
Heliyon|August 7, 2024
Nicotinamide riboside first alleviates symptoms but later downregulates dopamine metabolism in proteasome inhibition mouse model of Parkinson's diseaseGiorgio Turconi, Farhan Alam, Tanima SenGupta, et al.
Nature Communications|August 24, 2019
PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in gliomaNathan R Fons, Ranjini K Sundaram, Gregory A Breuer, et al.
Mechanisms of Ageing and Development|January 19, 2020
Targeting NAD<sup>+</sup> in translational research to relieve diseases and conditions of metabolic stress and ageingBrian C Gilmour, Ruben Gudmundsrud, Johannes Frank, et al.
Pageof 15

Showing results (121-130 of 147) with videos related to

Sort By:
Pageof 15
Brain, Behavior, and Immunity|November 5, 2024
Acute exercise boosts NAD<sup>+</sup> metabolism of human peripheral blood mononuclear cellsDavid Walzik, Niklas Joisten, Alexander Schenk, et al.
Eclinicalmedicine|December 8, 2025
Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trialChao-Yi Wu, William Cody Reynolds, Isabel Abril, et al.
Molecular Cell|May 6, 2020
NAD<sup>+</sup> Controls Circadian Reprogramming through PER2 Nuclear Translocation to Counter AgingDaniel C Levine, Heekyung Hong, Benjamin J Weidemann, et al.
Pediatric Blood & Cancer|October 10, 2024
Feasibility of telehealth exercise and nicotinamide riboside supplementation in survivors of childhood cancer at risk for diabetes: A pilot randomized controlled trialRusha Bhandari, Kara Lukas, Kyuwan Lee, et al.
Molecular Metabolism|July 29, 2017
Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cellsRachel S Fletcher, Joanna Ratajczak, Craig L Doig, et al.
Geroscience|November 23, 2023
A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairmentMiranda E Orr, Eithan Kotkowski, Paulino Ramirez, et al.
The Journal of Clinical Investigation|January 13, 2022
Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytesJing Wu, Komudi Singh, Amy Lin, et al.
Heliyon|August 7, 2024
Nicotinamide riboside first alleviates symptoms but later downregulates dopamine metabolism in proteasome inhibition mouse model of Parkinson's diseaseGiorgio Turconi, Farhan Alam, Tanima SenGupta, et al.
Nature Communications|August 24, 2019
PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in gliomaNathan R Fons, Ranjini K Sundaram, Gregory A Breuer, et al.
Mechanisms of Ageing and Development|January 19, 2020
Targeting NAD<sup>+</sup> in translational research to relieve diseases and conditions of metabolic stress and ageingBrian C Gilmour, Ruben Gudmundsrud, Johannes Frank, et al.
Pageof 15